Marching Into an Uncertain Future

Can professional organizations and societies parlay the groundswell of support culminating in this weekend’s March for Science into more-effective science advocacy?

Written byBob Grant
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

FLICKR, DCJOHNOn April 22, people will enter the public square to celebrate science and voice their support for the research enterprise in what’s expected to be unprecedented numbers. The March for Science comprises events planned across the globe, from Berlin to Chicago to Hong Kong. But the epicenter of the movement will be Washington, DC. This is, in part, because the march and the sentiment surrounding it were precipitated by the election of Donald Trump to the US presidency.

Although each new administration has a different take on science policy, professional science advocates are largely left scratching their heads as to where Trump stands on issues important to their members. “There’s no one, it appears to me, at 1600 Pennsylvania Avenue that particularly cares about science anymore. And that’s a different environment for us,” said Benjamin Corb, public affairs director at the American Society for Biochemistry and Molecular Biology (ASBMB). “It’s not unique. It’s not as if it’s the first time we’ve had to deal with this, but it’s different from where we had been for eight years. [Former President Barrack] Obama was, at a minimum, curious about science.”

Trump’s opacity with regard to his positions on science has propelled science advocacy to a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies